Evidence map›Paper›PMID 37829018›Full record

ArticleChemical science2023

A tunable family of CAAC-ruthenium olefin metathesis catalysts modularly derived from a large-scale produced ibuprofen intermediate.

Adrian Sytniczuk, Filip Struzik, Karol Grela, Anna Kajetanowicz

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Facile Access to Chelating CAArC-Phosphine (CAArCPhos) Palladium Complexes.Angewandte Chemie (International ed. in English) · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Adrian SytniczukBiological and Chemical Research Centre, Faculty of Chemistry, University of Warsaw Żwirki i Wigury 101 02-089 Warsaw Poland a.kajetanowicz@uw.edu.pl.ORCID https://orcid.org/0000-0002-4151-3326
Filip StruzikBiological and Chemical Research Centre, Faculty of Chemistry, University of Warsaw Żwirki i Wigury 101 02-089 Warsaw Poland a.kajetanowicz@uw.edu.pl.ORCID https://orcid.org/0000-0002-9659-0118
Karol GrelaBiological and Chemical Research Centre, Faculty of Chemistry, University of Warsaw Żwirki i Wigury 101 02-089 Warsaw Poland a.kajetanowicz@uw.edu.pl.ORCID https://orcid.org/0000-0001-9193-3305
Anna KajetanowiczBiological and Chemical Research Centre, Faculty of Chemistry, University of Warsaw Żwirki i Wigury 101 02-089 Warsaw Poland a.kajetanowicz@uw.edu.pl.ORCID https://orcid.org/0000-0003-0315-0998
University of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of tunable CAAC-based ruthenium benzylidene complexes with increased lipophilicity derived from a ketone being a large-scale produced key substrate for a popular nonsteroidal anti-inflammatory drug-ibuprofen was obtained and tested in various olefin metathesis transformations. As a group, these catalysts exhibited higher activity than their known analogues containing a smaller and less lipophilic phenyl substituent on the α-carbon atom, but in individual reactions, the size of the

Identifiers

PMID37829018
PMCPMC10566500
OpenAlexW4386972858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.